AbbVie Inc. Restructuring Reserve
AbbVie Inc. (ABBV) had Restructuring Reserve of $119.00 million as of 2020-03-31, per its 10-Q filed 2020-05-08.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2020-05-08
- 2020-03-31: Restructuring Reserve $119.00M.
- 2019-12-31: Restructuring Reserve $140.00M.
- 2019-09-30: Restructuring Reserve $160.00M.
- 2019-06-30: Restructuring Reserve $191.00M.
| Period end | Restructuring Reserve |
|---|---|
| 2020-03-31 | $119.00M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $140.00M 10-Q · filed 2020-05-08 |
| 2019-09-30 | $160.00M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $191.00M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $209.00M 10-Q · filed 2019-05-03 |
| 2018-12-31 | $99.00M 10-K · filed 2020-02-21 |
| 2018-09-30 | $87.00M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $88.00M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $101.00M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $86.00M 10-K · filed 2020-02-21 |
| 2017-09-30 | $56.00M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $64.00M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $73.00M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $87.00M 10-K · filed 2020-02-21 |
| 2016-09-30 | $90.00M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $110.00M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $128.00M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $148.00M 10-K · filed 2019-02-27 |
| 2015-09-30 | $108.00M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $109.00M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $119.00M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $122.00M 10-K · filed 2018-02-16 |
| 2013-12-31 | $191.00M 10-K · filed 2017-02-17 |
| 2013-09-30 | $178.00M 10-Q · filed 2013-11-12 |
| 2012-12-31 | $193.00M 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |